Skip to main content

Novavax Coronavirus Vaccine Candidate will be Manufactured in Baltimore

Maryland and the Region are leading the way in the development of COVID-19 trial vaccines: Emergent Biosolutions in Baltimore City will manufacture the drug product being developed by Novavax, a Maryland-headquartered biotech company that received $4 million in funding from the Coalition for Epidemic Preparedness Innovations (CEPI). Emergent Biosolutions also produced treatments for Ebola and Zika viruses, according to to #regiononpoint #biopharmaceutical #biotech #maryland #vaccine #coronavirus #covid19

Read More

Subscribe to our mailing list: